CHRS · Coherus Oncology, Inc. · Congressional Trades
$0.77
+0.02 (+2.82%)
At close · Nov 6
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$118.97M
Shares
154.50M
Volume · Nov 6
1.08M
Avg daily vol (3M)
1.45M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2023-01-23 | Shri Thanedar | Representative | Sell ST · Coherus BioSciences, Inc. (CHRS) | — | $15K - $50K | 2023-02-09 | 17d |
Showing 1–1 of 1 trades
Key facts
CIK
1512762
CUSIP
19249H103
13F (30d)
72 filings
49 filers
Visit website
Investor relations